Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Enoxaflo 80mg/0.8ml Injection

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Enoxaparin (80mg)

Overview Enoxaflo 80mg/0.8ml Injection

Enoflox 80mg/0.8ml injection is an antithrombotic medication employed to prevent and manage potentially dangerous blood clots. It inhibits the growth of existing clots and suppresses the development of new ones. This medication is also effective in preventing venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism. Administration of Enoflox 80mg/0.8ml injection is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration are tailored to individual patient factors, including medical history, response to therapy, and the specific condition being treated, also considering age and weight. Consistent use is crucial, even in the absence of noticeable symptoms, as its preventative effects are paramount; discontinuation may lead to clot formation. Activities increasing bleeding or injury risk should be avoided during treatment. Common adverse events include injection site discomfort, hemorrhage, cephalalgia, thrombocytosis, respiratory difficulties, edema, anemia, pyrexia, diarrhea, and elevated liver function tests. Severe headache may signal intracranial bleeding, while intense abdominal pain could indicate gastrointestinal bleeding. Hemorrhage, potentially life-threatening and not always readily apparent, necessitates vigilance and prompt medical consultation for any concerning symptoms. Prior to commencing therapy, inform your physician of any pre-existing conditions such as hypertension, diabetes mellitus, or recent cerebrovascular accident. The medication is contraindicated in individuals with active bleeding. Complete disclosure of all other medications is crucial to ensure treatment safety. Patients with low body mass may exhibit increased bleeding susceptibility, and alcohol consumption further elevates the risk of gastrointestinal bleeding.

Uses of Enoxaflo 80mg/0.8ml Injection

Preventing and managing blood clot formation

Major Benefits of Enoxaflo 80mg/0.8ml Injection:

A healthcare professional will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

Common Side effects of Enoxaflo 80mg/0.8ml Injection:

  • Bleeding
  • Headache
  • Low blood platelets
  • Increased liver enzymes
  • Anemia (low number of red blood cells)
  • Fever
  • Injection site pain
  • Breathing problems
  • Edema (swelling)
  • Diarrhea

How to use Enoxaflo 80mg/0.8ml Injection:

A healthcare professional will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

How Enoxaflo 80mg/0.8ml Injection works:

Enoxaparin 80mg/0.8ml Injection is a medication that thins the blood. Its mechanism involves neutralizing specific coagulation factors, thus inhibiting clot development and reducing the risk of vascular obstructions.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Enoxaparin (Enoxaflo 80mg/0.8ml Injection) and alcohol consumption: The safety of concurrent use is undetermined. Seek medical advice before combining.

PregnancyPregnancySAFE IF PRESCRIBED

During pregnancy, the injectable medication Enoxaflo 80mg/0.8ml is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Enoxaflo 80mg/0.8ml Injection safely. Available human data indicates minimal risk to the infant. The drug's transfer to breast milk is low, resulting in negligible infant exposure and an insignificant likelihood of adverse effects.

DrivingDrivingSAFE

Driving ability is typically unaffected by Enoxaparin 80mg/0.8ml injections.

KidneyKidneyCAUTION

Patients with kidney impairment should use Enoxaflo 80mg/0.8ml Injection cautiously, as dose modification may be necessary. Medical advice is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Enoxaflo 80mg/0.8ml Injection to individuals with hepatic impairment. Medical advice is recommended. Nevertheless, its application in patients exhibiting pre-existing liver conditions should be approached with prudence.

What if you forget to take Enoxaflo 80mg/0.8ml Injection :

Should you forget a dose of Enoxaflo 80mg/0.8ml Injection, seek advice from your physician.

Facts to Know About Enoxaflo 80mg/0.8ml Injection

LabelValue
Pharmaceutical Category Low-molecular-weight heparin (LMWH)
Potential for Dependence None.
Type of Medication Hematological
Mechanism of Action Low-molecular-weight heparin (LMWH)

FAQs on Enoxaflo 80mg/0.8ml Injection

Subcutaneous administration of Enoxaflo 80mg/0.8ml Injection is achieved by pinching a skin fold on the abdomen between thumb and forefinger. Following proper cleansing, the syringe, held like a pencil, is inserted fully into the fold. The medication is then injected completely. Dispose of the syringe according to your doctor's directions. Adhere strictly to your healthcare provider's instructions. Consult your physician immediately should any questions arise or adverse effects occur.
Prior to commencing treatment with Enoxaflo 80mg/0.8ml Injection, provide your physician with a comprehensive medical history. Disclose any pre-existing conditions, including heart valve replacement, peptic ulcer, hypertension, diabetes mellitus, or renal impairment. Further, report any prior adverse reactions to heparin or recent neurological events such as stroke or neurosurgery. These conditions may heighten the risk of adverse events. Adhere precisely to your physician's prescribed regimen and seek ongoing medical guidance.
Keep Enoxaflo 80mg/0.8ml Injection vials at a temperature of 25°C and protect from freezing. Multi-dose vials are stable for a maximum of 28 days following initial access. Dispose of the injection if cloudiness, discoloration, or syringe damage is observed. Consult the patient information leaflet prior to administration and seek pharmacist advice for any uncertainties.
Enoxaparin 80mg/0.8ml injection is administered in the management of chest pain and myocardial infarction following initial treatment. It's typically co-administered with an antiplatelet agent such as aspirin. Its anticoagulant properties inhibit blood coagulation, thereby mitigating the risk of recurrent events and associated complications.
Air bubbles within the syringe should be expelled into the injection site. Failure to do so results in medication loss and an inaccurate dosage.
Enoxaflo 80mg/0.8ml Injec...
606
MRP 738
17% off